Correct..the major dilution and maxing out OS followed by another RS as some have predicted need some buyers with cash to drive the ticker. Anemic volume won't accomplish the task. The covid-19 hype has already been played and fizzled.. the cancer cure is still out there but has been shelved..Ridgeway seems to be a cold case..nothing has been said or known about MediciNova..none of the irons in the fire are working out. However, stay tuned for something coming from somewhere or maybe from nowhere to bust the ticker loose!
News 
Market Data 
Discover 
